List of Excipients in API oxcarbazepine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing oxcarbazepine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | TRILEPTAL | oxcarbazepine | 0078-0456 | CELLULOSE, MICROCRYSTALLINE | |
| Novartis Pharmaceuticals Corporation | TRILEPTAL | oxcarbazepine | 0078-0456 | CROSPOVIDONE | |
| Novartis Pharmaceuticals Corporation | TRILEPTAL | oxcarbazepine | 0078-0456 | FERRIC OXIDE YELLOW | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing oxcarbazepine
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 | ASCORBIC ACID |
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 | CARBOXYMETHYLCELLULOSE SODIUM |
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 | CELLULOSE, MICROCRYSTALLINE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for oxcarbazepine
Excipient focus: ALCOHOL
oxcarbazepine drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALUMINUM OXIDE
oxcarbazepine drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | oxcarbazepine | 50090-5003 |
| Breckenridge Pharmaceutical Inc | oxcarbazepine | 51991-292 |
| Quality Care Products LLC | oxcarbazepine | 55700-868 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: ASCORBIC ACID
oxcarbazepine drug variants containing ASCORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-687 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing ASCORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6594 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE
oxcarbazepine drug variants containing CARBOXYMETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | oxcarbazepine | 50383-312 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing CARBOXYMETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
oxcarbazepine drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-687 |
| EPIC PHARMA LLC | oxcarbazepine | 42806-600 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6594 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
oxcarbazepine drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| EPIC PHARMA LLC | oxcarbazepine | 42806-600 |
| AvPAK | oxcarbazepine | 50268-649 |
| Taro Pharmaceuticals USA Inc | oxcarbazepine | 51672-4105 |
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
oxcarbazepine drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | oxcarbazepine | 63304-653 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
oxcarbazepine drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6594 |
| NCS HealthCare of KY LLC dba Vangard Labs | oxcarbazepine | 0615-8153 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY LLC dba Vangard Labs | oxcarbazepine | 0615-8447 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
oxcarbazepine drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6594 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| Supernus Pharmaceuticals Inc | oxcarbazepine | 17772-121 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
oxcarbazepine drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | oxcarbazepine | 50090-5003 |
| Breckenridge Pharmaceutical Inc | oxcarbazepine | 51991-292 |
| Cardinal Health 107 LLC | oxcarbazepine | 55154-8187 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2 ALUMINUM LAKE
oxcarbazepine drug variants containing FD&C BLUE NO. 2 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | oxcarbazepine | 0904-7262 |
| Cardinal Health 107 LLC | oxcarbazepine | 55154-4323 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing FD&C BLUE NO. 2 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 5
oxcarbazepine drug variants containing FD&C YELLOW NO. 5
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | oxcarbazepine | 50090-5003 |
| Breckenridge Pharmaceutical Inc | oxcarbazepine | 51991-292 |
| Cardinal Health 107 LLC | oxcarbazepine | 55154-8187 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing FD&C YELLOW NO. 5
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 5 ALUMINUM LAKE
oxcarbazepine drug variants containing FD&C YELLOW NO. 5 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | oxcarbazepine | 0904-7262 |
| Cardinal Health 107 LLC | oxcarbazepine | 55154-4323 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing FD&C YELLOW NO. 5 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
oxcarbazepine drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | oxcarbazepine | 50090-5003 |
| Breckenridge Pharmaceutical Inc | oxcarbazepine | 51991-292 |
| Cardinal Health 107 LLC | oxcarbazepine | 55154-8187 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6 ALUMINUM LAKE
oxcarbazepine drug variants containing FD&C YELLOW NO. 6 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | oxcarbazepine | 0904-7262 |
| Cardinal Health 107 LLC | oxcarbazepine | 55154-4323 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing FD&C YELLOW NO. 6 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
oxcarbazepine drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | oxcarbazepine | 0615-8447 |
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-023 |
| AvPAK | oxcarbazepine | 50268-679 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
oxcarbazepine drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6594 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| Major Pharmaceuticals | oxcarbazepine | 0904-7262 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
oxcarbazepine drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | oxcarbazepine | 0615-8447 |
| Ajanta Pharma USA Inc | oxcarbazepine | 27241-237 |
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-023 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
oxcarbazepine drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| AvPAK | oxcarbazepine | 50268-649 |
| Amneal Pharmaceuticals LLC | oxcarbazepine | 65162-649 |
| Precision Dose Inc | oxcarbazepine | 68094-123 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYL CELLULOSE
oxcarbazepine drug variants containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| EPIC PHARMA LLC | oxcarbazepine | 42806-600 |
| Ranbaxy Pharmaceuticals Inc | oxcarbazepine | 63304-653 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
oxcarbazepine drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | oxcarbazepine | 27241-237 |
| REMEDYREPACK INC | oxcarbazepine | 70518-4079 |
| Advagen Pharma Limited | oxcarbazepine | 72888-087 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
oxcarbazepine drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | oxcarbazepine | 0904-7262 |
| Supernus Pharmaceuticals Inc | oxcarbazepine | 17772-121 |
| Ajanta Pharma USA Inc | oxcarbazepine | 27241-237 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2208
oxcarbazepine drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | oxcarbazepine | 60505-4128 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
oxcarbazepine drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | oxcarbazepine | 0615-8447 |
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-023 |
| AvPAK | oxcarbazepine | 50268-679 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
oxcarbazepine drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6594 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| NCS HealthCare of KY LLC dba Vangard Labs | oxcarbazepine | 0615-8447 |
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| >Company | >Ingredient | >NDC |
Excipient focus: LECITHIN, SOYBEAN
oxcarbazepine drug variants containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | oxcarbazepine | 50090-5003 |
| Breckenridge Pharmaceutical Inc | oxcarbazepine | 51991-292 |
| Cardinal Health 107 LLC | oxcarbazepine | 55154-8187 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: LEMON
oxcarbazepine drug variants containing LEMON
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-687 |
| Biocon Pharma Inc | oxcarbazepine | 70377-117 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing LEMON
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
oxcarbazepine drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY LLC dba Vangard Labs | oxcarbazepine | 0615-8447 |
| Major Pharmaceuticals | oxcarbazepine | 0904-7262 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6594 |
| >Company | >Ingredient | >NDC |
Excipient focus: MALIC ACID
oxcarbazepine drug variants containing MALIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| AvPAK | oxcarbazepine | 50268-649 |
| Amneal Pharmaceuticals LLC | oxcarbazepine | 65162-649 |
| Precision Dose Inc | oxcarbazepine | 68094-123 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing MALIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: MEGLUMINE
oxcarbazepine drug variants containing MEGLUMINE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | oxcarbazepine | 21695-862 |
| Physicians Total Care Inc | oxcarbazepine | 54868-5830 |
| DIRECT RX | oxcarbazepine | 61919-569 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing MEGLUMINE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
oxcarbazepine drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | oxcarbazepine | 17772-121 |
| Ajanta Pharma USA Inc | oxcarbazepine | 27241-304 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLCELLULOSE
oxcarbazepine drug variants containing METHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| REMEDYREPACK INC | oxcarbazepine | 70518-4079 |
| Advagen Pharma Limited | oxcarbazepine | 72888-087 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing METHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
oxcarbazepine drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-687 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6594 |
| >Company | >Ingredient | >NDC |
Excipient focus: NONCRYSTALLIZING SORBITOL SOLUTION
oxcarbazepine drug variants containing NONCRYSTALLIZING SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-687 |
| Medley Pharmaceuticals Limited | oxcarbazepine | 42934-401 |
| NorthStar RxLLC | oxcarbazepine | 72603-252 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing NONCRYSTALLIZING SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: PEG-8 STEARATE
oxcarbazepine drug variants containing PEG-8 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-687 |
| EPIC PHARMA LLC | oxcarbazepine | 42806-600 |
| Akorn | oxcarbazepine | 50383-312 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing PEG-8 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: PLUM
oxcarbazepine drug variants containing PLUM
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing PLUM
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
oxcarbazepine drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY LLC dba Vangard Labs | oxcarbazepine | 0615-8153 |
| Major Pharmaceuticals | oxcarbazepine | 0904-7262 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6594 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 2000
oxcarbazepine drug variants containing POLYETHYLENE GLYCOL 2000
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | oxcarbazepine | 17772-121 |
| Ajanta Pharma USA Inc | oxcarbazepine | 27241-304 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing POLYETHYLENE GLYCOL 2000
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
oxcarbazepine drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | oxcarbazepine | 0615-8447 |
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-023 |
| AvPAK | oxcarbazepine | 50268-679 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
oxcarbazepine drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
oxcarbazepine drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | oxcarbazepine | 60505-4128 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
oxcarbazepine drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6594 |
| Aidarex Pharmaceuticals LLC | oxcarbazepine | 33261-684 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY LLC dba Vangard Labs | oxcarbazepine | 0615-8153 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 8 STEARATE
oxcarbazepine drug variants containing POLYOXYL 8 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Medley Pharmaceuticals Limited | oxcarbazepine | 42934-401 |
| Bionpharma Inc | oxcarbazepine | 69452-125 |
| Kesin Pharma | oxcarbazepine | 81033-113 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing POLYOXYL 8 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
oxcarbazepine drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6594 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY LLC dba Vangard Labs | oxcarbazepine | 0615-8447 |
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
oxcarbazepine drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | oxcarbazepine | 0615-8447 |
| Major Pharmaceuticals | oxcarbazepine | 0904-7262 |
| Supernus Pharmaceuticals Inc | oxcarbazepine | 17772-121 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
oxcarbazepine drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | oxcarbazepine | 17772-121 |
| Ajanta Pharma USA Inc | oxcarbazepine | 27241-237 |
| Ajanta Pharma USA Inc | oxcarbazepine | 27241-304 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
oxcarbazepine drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6594 |
| NCS HealthCare of KY LLC dba Vangard Labs | oxcarbazepine | 0615-8153 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY LLC dba Vangard Labs | oxcarbazepine | 0615-8447 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONES
oxcarbazepine drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | oxcarbazepine | 63304-653 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
oxcarbazepine drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-687 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6594 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
oxcarbazepine drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-687 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6594 |
| >Company | >Ingredient | >NDC |
Excipient focus: SACCHARIN SODIUM
oxcarbazepine drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-687 |
| EPIC PHARMA LLC | oxcarbazepine | 42806-600 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: SACCHARIN SODIUM ANHYDROUS
oxcarbazepine drug variants containing SACCHARIN SODIUM ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing SACCHARIN SODIUM ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6594 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
oxcarbazepine drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6594 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-687 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BENZOATE
oxcarbazepine drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| AvPAK | oxcarbazepine | 50268-649 |
| Amneal Pharmaceuticals LLC | oxcarbazepine | 65162-649 |
| Precision Dose Inc | oxcarbazepine | 68094-123 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
oxcarbazepine drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| AvPAK | oxcarbazepine | 50268-649 |
| Amneal Pharmaceuticals LLC | oxcarbazepine | 65162-649 |
| Precision Dose Inc | oxcarbazepine | 68094-123 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
oxcarbazepine drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | oxcarbazepine | 17772-121 |
| Ajanta Pharma USA Inc | oxcarbazepine | 27241-237 |
| Ajanta Pharma USA Inc | oxcarbazepine | 27241-304 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
oxcarbazepine drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6594 |
| NCS HealthCare of KY LLC dba Vangard Labs | oxcarbazepine | 0615-8153 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY LLC dba Vangard Labs | oxcarbazepine | 0615-8447 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBIC ACID
oxcarbazepine drug variants containing SORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-687 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing SORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6594 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
oxcarbazepine drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| AvPAK | oxcarbazepine | 50268-649 |
| Akorn | oxcarbazepine | 50383-312 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL SOLUTION
oxcarbazepine drug variants containing SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| EPIC PHARMA LLC | oxcarbazepine | 42806-600 |
| Biocon Pharma Inc | oxcarbazepine | 70377-117 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: SOYBEAN LECITHIN
oxcarbazepine drug variants containing SOYBEAN LECITHIN
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | oxcarbazepine | 0904-7262 |
| Cardinal Health 107 LLC | oxcarbazepine | 55154-4323 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing SOYBEAN LECITHIN
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
oxcarbazepine drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| AvPAK | oxcarbazepine | 50268-649 |
| Amneal Pharmaceuticals LLC | oxcarbazepine | 65162-649 |
| Precision Dose Inc | oxcarbazepine | 68094-123 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
oxcarbazepine drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6594 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
oxcarbazepine drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY LLC dba Vangard Labs | oxcarbazepine | 0615-8447 |
| Major Pharmaceuticals | oxcarbazepine | 0904-7262 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6594 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
oxcarbazepine drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6594 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-687 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
oxcarbazepine drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6594 |
| NCS HealthCare of KY LLC dba Vangard Labs | oxcarbazepine | 0615-8153 |
| >Company | >Ingredient | >NDC |
Excipient focus: XANTHAN GUM
oxcarbazepine drug variants containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Medley Pharmaceuticals Limited | oxcarbazepine | 42934-401 |
| AvPAK | oxcarbazepine | 50268-649 |
| Amneal Pharmaceuticals LLC | oxcarbazepine | 65162-649 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Novartis Pharmaceuticals Corporation | oxcarbazepine | 0078-0456 |
| NCS HealthCare of KY Inc dba Vangard Labs | oxcarbazepine | 0615-6593 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
